🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/12/2018 | 0,5248 USD |
| 14/09/2018 | 0,4580 USD |
| 14/06/2018 | 0,4580 USD |
| 14/03/2018 | 0,4580 USD |
| 14/12/2017 | 0,4580 USD |
| 14/09/2017 | 0,4485 USD |
| 13/06/2017 | 0,4485 USD |
| 13/03/2017 | 0,4485 USD |
| 13/12/2016 | 0,4485 USD |
| 13/09/2016 | 0,4389 USD |
| 13/06/2016 | 0,4389 USD |
| 11/03/2016 | 0,4389 USD |
| 11/12/2015 | 0,4389 USD |
| 11/09/2015 | 0,4294 USD |
| 11/06/2015 | 0,4294 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/03/1977 | 1,48 | 1,51 | 1,48 | 1,50 | +1,12% | 1,79% | 2.195.770 |
| 01/03/1977 | 1,49 | 1,49 | 1,47 | 1,48 | -0,44% | 1,33% | 2.305.181 |
| 28/02/1977 | 1,49 | 1,49 | 1,47 | 1,49 | -0,22% | 0,89% | 1.633.622 |
| 25/02/1977 | 1,49 | 1,49 | 1,47 | 1,49 | -0,67% | 1,33% | 2.603.232 |
| 24/02/1977 | 1,53 | 1,53 | 1,49 | 1,50 | -2,37% | 2,81% | 2.237.270 |
| 23/02/1977 | 1,55 | 1,56 | 1,53 | 1,54 | -0,86% | 1,92% | 1.154.477 |
| 22/02/1977 | 1,53 | 1,55 | 1,53 | 1,55 | +1,52% | 1,30% | 2.003.357 |
| 18/02/1977 | 1,51 | 1,53 | 1,50 | 1,53 | +0,88% | 1,53% | 1.826.035 |
| 17/02/1977 | 1,54 | 1,54 | 1,51 | 1,51 | -1,51% | 1,72% | 1.980.720 |
| 16/02/1977 | 1,55 | 1,55 | 1,53 | 1,54 | -0,86% | 1,28% | 1.769.443 |
| 15/02/1977 | 1,55 | 1,56 | 1,53 | 1,55 | +0,21% | 1,71% | 2.539.094 |
| 14/02/1977 | 1,56 | 1,56 | 1,53 | 1,55 | -0,85% | 1,91% | 2.422.138 |
| 11/02/1977 | 1,57 | 1,58 | 1,54 | 1,56 | -0,64% | 2,11% | 4.463.222 |
| 10/02/1977 | 1,57 | 1,58 | 1,56 | 1,57 | +0,00% | 1,48% | 924.336 |
| 09/02/1977 | 1,57 | 1,58 | 1,55 | 1,57 | +0,00% | 1,90% | 1.709.078 |
| 08/02/1977 | 1,58 | 1,58 | 1,56 | 1,57 | -0,42% | 1,26% | 1.124.294 |
| 07/02/1977 | 1,57 | 1,58 | 1,57 | 1,58 | +0,85% | 1,06% | 2.471.184 |
| 04/02/1977 | 1,56 | 1,58 | 1,56 | 1,56 | +0,00% | 1,27% | 1.969.402 |
| 03/02/1977 | 1,56 | 1,56 | 1,55 | 1,56 | +0,21% | 0,85% | 2.025.994 |
| 02/02/1977 | 1,55 | 1,59 | 1,55 | 1,56 | +0,64% | 2,56% | 4.312.310 |
| 01/02/1977 | 1,53 | 1,56 | 1,53 | 1,55 | +1,08% | 1,94% | 2.754.144 |
| 31/01/1977 | 1,51 | 1,54 | 1,50 | 1,53 | +1,54% | 2,63% | 3.335.155 |
| 28/01/1977 | 1,56 | 1,56 | 1,50 | 1,51 | -3,59% | 3,81% | 8.971.718 |
| 27/01/1977 | 1,56 | 1,58 | 1,55 | 1,57 | +0,21% | 2,12% | 2.765.462 |
| 26/01/1977 | 1,58 | 1,58 | 1,56 | 1,56 | -0,84% | 1,26% | 2.078.813 |
| 25/01/1977 | 1,60 | 1,60 | 1,56 | 1,58 | -1,65% | 2,48% | 4.308.538 |
| 24/01/1977 | 1,65 | 1,65 | 1,60 | 1,60 | -2,62% | 2,82% | 2.603.232 |
| 21/01/1977 | 1,65 | 1,66 | 1,65 | 1,65 | +0,41% | 1,00% | 2.418.365 |
| 20/01/1977 | 1,70 | 1,71 | 1,62 | 1,64 | -3,70% | 4,86% | 2.557.958 |
| 19/01/1977 | 1,69 | 1,71 | 1,66 | 1,70 | +0,59% | 2,55% | 1.414.800 |